Adaptyx Biosciences

Adaptyx Biosciences has pioneered a programmable biowearable platform for continuous multi-analyte molecular monitoring via small wearable patches. At the core of Adaptyx technology are synthetic DNA-based molecular switches that enable continuous lab-grade molecular sensing. This sensing capability allows the patch to collect and transmit continuous biochemical data, supporting early intervention and more precise AI-assisted care in clinical and everyday health applications. Founded in 2022 and headquartered in Menlo Park, California, the company is initially seeking FDA clearance for clinical applications and plans to expand into broader health and wellness markets.